- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Winston Collins: Chronic Pain Often Brings a Need for Psychosocial Services
Chronic pain is often associated with depression or dysphoria as people can no longer do all the things they want, which may require psychosocial services, said Winston Collins, PhD, program director for substance use services at the John F. Kennedy Behavioral Health Centers.
Chronic pain is often associated with depression or dysphoria as people can no longer do all the things they want, which may require psychosocial services, said Winston Collins, PhD, program director for substance use services at the John F. Kennedy Behavioral Health Centers.
Transcript
What are some of the best psychosocial methods to help patients with chronic pain?
If you look at chronic pain, chronic pain brings with it, I think in many cases, a need for psychosocial services. Many folk who are suffering from chronic pain, also suffer from major depressive disorder or some sort of dysphoria. So, we do want to connect folk who are having chronic pain and they’re getting medication and they’re using those medications appropriately.
Maybe the pain medicine helps to increase their functionality to a degree, but they still can’t do the things that they would love to do. Like maybe, hold their child up at a certain level and play with them. They can’t do it. So, it can come with some dysphoria, it can come with some depression. So, we can use therapies, such as CBT, cognitive behavioral therapy, to kind of help them work through any emotional or mental health issue that goes along with the chronic pain.
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
A Novel Approach to Chronic GVHD With Axatilimab: Dr Daniel Wolff
October 18th 2024The latest therapy approved to treat chronic graft-versus-host disease (GVHD) has a new target different than the other approved therapies. Daniel Wolff, MD, also discusses future research on axatilimab to treat chronic GVHD earlier.
Read More
Bimekizumab Poised to Tackle Unmet HS Treatment Needs
October 18th 2024Hidradenitis suppurativa (HS) is an inflammatory, chronic disease with very high symptom and physical burdens, and it can get progressively worse over time if it's inadequately treated, explained Amit Garg, MD, founding chair, Department of Dermatology, Northwell Health.
Read More
